News & Videos - FERMENTALG - English

Libourne, February 13, 2025 - Fermentalg, a key player in bio-solutions based on aquatic micro-organisms, proudly announces three major milestones reinforcing its commitment to food safety, sustainability, and innovation. Strengthening trust and excellence with FSSC 22000 certification Fermentalg is proud to have obtained the FSSC 22000 certification, an internationally recognized standard for food safety management. This milestone demonstrates our firm dedication to ensuring product quality,...

Libourne, February 6, 2024 - Fermentalg, a key player in bio-solutions based on aquatic micro-organisms, today unveils the progress of its strategic transformation initiated a year ago under the impetus of its CEO, Pierre Josselin. With 15 years of expertise in biotechnology, Fermentalg has established itself as a key player in the creation of natural bio-solutions based on aquatic micro-organisms, responding to the challenges of global health ( One Health ) and sustainable development, with a...

Libourne - January 15, 2025 - Fermentalg (Euronext Growth / ALGAE) publishes its financial agenda for the year 2024. Date Nature January 14, 2025 2024 Four quarter financial information (after market closing) March 20, 2025 2024 Annual results (after market closing) April 2, 2025 2025 First quarter financial information (after market closing) July 8, 2025 2025 Second quarter financial information (after market closing) Septembre 11, 2025 2025 Half-year results (after market closing) Octobre 7,...

Libourne - January 14, 2025 - Fermentalg (Euronext Growth / ALGAE) announces record annual sales for 2024 [1] and confirms its growth trajectory to reach profitability by 2026. Sales multiplied by almost 3 in 1 year Fermentalg closed a record 2024 financial year in terms of sales, with sales of €11.5 million, significantly higher than those of 2023 (€4 million) and the target set at the beginning of last year (€10 million). This performance is all the more remarkable given that Fermentalg...

Libourne - October 7, 2024 - Fermentalg (Euronext Growth / ALGAE), expert French microalgae specialist, is proud to have once again been recognized by EthiFinance and EcoVadis for the quality of its extra-financial performance. First in EthiFinance's sector ranking As every year, Fermentalg has been evaluated by EthiFinance ESG Ratings, the agency specialized in rating the ESG performance of small and medium-sized companies listed on European markets. Under EthiFinance ESG Ratings 2024,...

Libourne - October 3 , 2024 - Fermentalg (Euronext Growth / ALGAE) announces its unaudited sales to the end of September 2024 and provides an update on its commercial activity. Sales multiplied by almost 3 in 1 year At the end of September 2024, Fermentalg confirmed its new sales momentum, with sales of €9.7 million, compared with €3.3 million at the end of September 2023, an almost 3-fold increase, and €6.2 million at the end of September 2022, the previous high. This performance is due...

Libourne - September 17, 2024 - Fermentalg (Euronext Growth / ALGAE), expert French microalgae company, presents its results for the 1 st half-year of the 2024 financial year, following approval of the accounts by the Board of Directors at its meeting today [1] . These results confirm the relevance of the new strategic plan and its two pillars: boosting sales by opening up new markets and strengthening strategic partnerships. 2.7-fold increase in sales of DHA Origins® and outlook confirmed...

Libourne - July 4, 2024 - Fermentalg (Euronext Growth / ALGAE) announces its unaudited sales for the 1 er half-year 2024 and looks back on the main advances in its roadmap to consolidate its position as European leader in sustainable solutions based on marine microalgae biotechnology. Sales momentum restored and annual target raised As announced in its press release of 17 June 2024, Fermentalg regained a very solid sales momentum in the 1 er half-year 2024. At the end of June, the Company...

Libourne - 18 June 2024 - Fermentalg (Euronext Growth / ALGAE) today announced the successful completion of a €12.8 million capital increase designed to further execute its 2024-2026 strategic plan and consolidate its position as the European leader in sustainable solutions based on marine microalgae biotechnology. The HuvePharma group, European leader in precision fermentation [1] in the animal and human health sectors, and a new industrial partner of the Company since December 2023 [2] ,...

Press release Launch of a capital increase open to institutional and retail investors for a total of approximately €12 million, with the support of HuvePharma, Fermentalg's industrial partner, to create the European leader for microalgae fermentation solutions Fundraising of approximately €12 million, comprising (i) an offer to qualified investors via the accelerated construction of an order book, (ii) an offer reserved for a category of beneficiaries, and (iii) a public offer to individual...

Libourne - May 14, 2024 - Fermentalg, France's leading microalgae company listed on Euronext (ALGAE), provides an update on its 2024 roadmap, on the opening day of Vitafoods Europe 2024, one of the world's leading events for the nutraceutical industry. An acceleration in sales in the 2 nd quarter of 2024, with the prospect of a first half well ahead of the annual target of €10 million After a 77% growth in the 1 st quarter of 2024, which enabled Fermentalg to record its best sales quarter...

Libourne - April 3, 2024 - Fermentalg, the French leader in microalgae listed on Euronext (FALG), today unveils its unaudited sales figures for the 1 st quarter of 2024, which confirm the new commercial momentum resulting from the 2024 - 2026 strategic plan unveiled at the end of 2023 [1] in favor of profitable and sustainable growth. The Company confirms its targets for 2024 and 2026. Sales up 77% in 1 st quarter 2024... In the 1 st quarter of 2024, Fermentalg posted sales of €2.7 million, up...

Libourne - April 3, 2024 - Fermentalg, the French leader in microalgae listed on Euronext (FALG), today unveils its 2023 annual results [1] . Pierre Josselin, Chief Executive Officer of Fermentalg, comments: " In 2023, we were hit by soaring energy and raw materials prices and rising interest rates, but also by short-term commercial difficulties linked to the reduction in purchases by two major customers. We are approaching 2024 with much greater confidence. The new strategic plan deployed since...

Libourne – February 6, 2024 – The General Assembly of Fermentalg (FALG), meeting on February 2, 2024, approved in accordance with the provisions of Article L.421-14 of the French Monetary and Financial Code, the proposed listing transfer of its securities on the regulated market Euronext Paris (Subfund C), to Euronext Growth Paris, and conferred all powers to the Board of Directors to implement this listing market transfer. The Board of Directors, which met on 5 February 2024, decided to...

Libourne - January 25, 2024 - Fermentalg, the French leader in microalgae listed on Euronext (FALG), today unveils its 2023 sales figures and 2024 outlook, fueled by orders and commercial contracts at an all-time high at the start of the financial year. This new sales momentum is the first fruit of the 2024 - 2026 strategic plan unveiled at the end of 2023 [1] in favor of profitable, sustainable growth. Thanks to this roadmap focused on accelerating sales, developing strategic partnerships and...

Libourne - January 22, 2024 - Fermentalg, the French leader in microalgae listed on Euronext (FALG), publishes its financial agenda for the year 2024. Date Nature January 25, 2024 2023 Four quarter financial information (after market closing) April 3, 2024 2023 Annual results (after market closing) April 3, 2024 2024 First quarter financial information (after market closing) July 4, 2024 2024 Second quarter financial information (after market closing) Septembre 17, 2024 2024 Half-year results...

Libourne - December 19, 2023 - Fermentalg, the French leader in microalgae listed on Euronext (FALG), today unveils its 2024 - 2026 strategic plan, marking a crucial step in its commitment to profitable, sustainable growth. Defined under the leadership of new CEO Pierre Josselin, the strategic plan aims for sustained growth, with a target of over €25 million in sales by 2026, a more than 6-fold increase on sales of around €4 million in 2023. With this roadmap focused on accelerating sales,...

Libourne - July 19, 2023 - Fermentalg (Euronext - FALG), a French expert in microalgae, published today its sales figures for the 1 er half-year of the 2023 financial year [1] and announced the presentation next fall of the major orientations of the new strategic plan prepared under the leadership of its new CEO, Pierre Josselin. Pierre Josselin commented: " My first few weeks at Fermentalg have confirmed my belief in the company's growth potential. The excellence of our teams' expertise in...

Separation of the functions of Chairman and Chief Executive Officer; Proposed reappointment of Philippe Lavielle as Chairman of the Board of Directors; Proposed appointment of Pierre Josselin as Chief Executive Officer and Director. Libourne - May 4, 2023 - The Board of Directors of Fermentalg, meeting today, on the recommendation of the Nomination and Remuneration Committee, has unanimously validated the principle of separating the functions of Chairman of the Board of Directors and Chief...

Libourne - March 15, 2023 - Fermentalg (Euronext - FALG), the French microalgae expert, announces that it has completed as of March 14 th a €6.3 million convertible bond issue subscribed by four European investors. Philippe Lavielle, CEO of Fermentalg, said: « The year 2023 promises to be an important one for Fermentalg with the start of industrial production and the pre-commercialization phases of our natural blue food colorant BLUE ORIGINS® and more generally with the gradual expansion of...